Candel Therapeutics
(NASDAQ:CADL)
$1.65
-0.13[-7.30%]
At close: Feb 27
$1.65
0[0.00%]
PreMarket: 7:13AM EDT

GET A REPORT ON CADL SENT RIGHT TO YOUR INBOX

Candel Therapeutics Stock (NASDAQ:CADL), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Outperform
Highest Price Target1
$22.00
Lowest Price Target1
$3.00
Consensus Price Target1
$11.71

Analyst Rating Summary1

Analyst Ratings
Nov 23
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
BMO Capital
Credit Suisse
UBS
Jefferies

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Candel Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
11/13/2023CADLBuy Now
Candel Therapeutics
$1.65566.67%HC Wainwright & Co.
Vernon Bernardino
→ $11ReiteratesBuy → BuyGet Alert
05/22/2023CADLBuy Now
Candel Therapeutics
$1.65566.67%HC Wainwright & Co.
Vernon Bernardino
→ $11ReiteratesBuy → BuyGet Alert
05/15/2023CADLBuy Now
Candel Therapeutics
$1.6581.82%BMO Capital
Evan David Seigerman
$9 → $3MaintainsOutperformGet Alert
03/31/2023CADLBuy Now
Candel Therapeutics
$1.65324.24%Credit Suisse
Judah Frommer
$8 → $7MaintainsOutperformGet Alert
12/07/2022CADLBuy Now
Candel Therapeutics
$1.65384.85%Credit Suisse
Judah Frommer
$10 → $8MaintainsOutperformGet Alert
12/02/2022CADLBuy Now
Candel Therapeutics
$1.65566.67%HC Wainwright & Co.
Vernon Bernardino
→ $11Initiates → BuyGet Alert
03/31/2022CADLBuy Now
Candel Therapeutics
$1.65627.27%BMO Capital
Evan Seigerman
$18 → $12MaintainsOutperformGet Alert
11/19/2021CADLBuy Now
Candel Therapeutics
$1.65990.91%BMO CapitalInitiates → OutperformGet Alert
08/23/2021CADLBuy Now
Candel Therapeutics
$1.65445.45%UBS
Colin Bristow
Initiates → BuyGet Alert
08/23/2021CADLBuy Now
Candel Therapeutics
$1.651233.33%Jefferies
Chris Howerton
Initiates → BuyGet Alert
08/23/2021CADLBuy Now
Candel Therapeutics
$1.65809.09%Credit Suisse
Judah Frommer
Initiates → OutperformGet Alert

FAQ

Q

What is the target price for Candel Therapeutics (CADL)?

A

The latest price target for Candel Therapeutics (NASDAQ: CADL) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $11.00 expecting CADL to rise to within 12 months (a possible 566.67% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Candel Therapeutics (CADL)?

A

The latest analyst rating for Candel Therapeutics (NASDAQ: CADL) was provided by HC Wainwright & Co., and Candel Therapeutics reiterated their buy rating.

Q

When is the next analyst rating going to be posted or updated for Candel Therapeutics (CADL)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Candel Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Candel Therapeutics was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.

Q

Is the Analyst Rating Candel Therapeutics (CADL) correct?

A

While ratings are subjective and will change, the latest Candel Therapeutics (CADL) rating was a reiterated with a price target of $0.00 to $11.00. The current price Candel Therapeutics (CADL) is trading at is $1.65, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch